AJP Legacy Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol 196: 1029-1032, 1959;
0002-9513/59 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fozzard, H. A.
Right arrow Articles by Gilmore, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fozzard, H. A.
Right arrow Articles by Gilmore, J. P.

Use of levarterenol in treatment of irreversible hemorrhagic shock

H. A. Fozzard 1 and J. P. Gilmore 1

1 Department of Physiology, Naval Medical Field Research Laboratory, Camp Lejeune, North Carolina

The effectiveness of levarterenol in the treatment of shock resulting from prolonged oligemia was studied in the dog. The survival time of animals receiving levarterenol and whole blood therapy was significantly greater than that of animals receiving a placebo and whole blood. The results of the experiments indicate that levarterenol is an effective adjunct to whole blood therapy in the treatment of shock resulting from prolonged hemorrhagic hypotension.

Note:
With the Assistance of H. R. Fallers, Jr., M. G. Moore, Jr., R. Jackson, D. C. Davis and C. W. Newhall, Jr.

Submitted on October 5, 1958




This article has been cited by other articles:


Home page
 Circ. Res.Home page
H. A. Fozzard
Fifty Years of Cardiovascular Science Together
Circ. Res., January 10, 2003; 92(1): 4 - 5.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1959 by the American Physiological Society.